We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
(+8.4%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
177.31%
Top 10 Holdings %
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127
Top Buys
| 1 |
Procter & Gamble
PG
|
+$3.82M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.47M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2M |
| 4 |
Ulta Beauty
ULTA
|
+$1.86M |
| 5 |
MON
Monsanto Co
MON
|
+$1.82M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$7.18M |
| 2 |
Biogen
BIIB
|
+$4.33M |
| 3 |
Cal-Maine
CALM
|
+$3.64M |
| 4 |
Apple
AAPL
|
+$2.74M |
| 5 |
ALR
Alere Inc
ALR
|
+$2.22M |
Sector Composition
| 1 | Healthcare | 39.95% |
| 2 | Consumer Staples | 5.72% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Technology | 3.35% |
| 5 | Materials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PUT
NetEase
NTES
$84.1B
| $5K | ﹤0.01% |
+50,000
| New | +$2.13M |
|
327
PUT
NXP Semiconductors
NXPI
$67.3B
| $5K | ﹤0.01% |
+10,600
| New | +$898K |
|
328
PUT
PepsiCo
PEP
$187B
| $5K | ﹤0.01% |
+17,500
| New | +$1.89M |
|
|
JUNO
329
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
| $5K | ﹤0.01% |
40,000
-20,000
| -33% | -$622K |
|
|
AVG
330
PUT
DELISTED
AVG Technologies N.V.
AVG
| $5K | ﹤0.01% |
+10,600
| New | +$260K |
|
331
CALL
Hershey
HSY
$34.8B
| $4K | ﹤0.01% |
17,500
-25,600
| -59% | -$2.71M |
|
332
CALL
Silicon Motion
SIMO
$8.96B
| $4K | ﹤0.01% |
+5,500
| New | +$287K |
|
|
ENDP
333
PUT
DELISTED
Endo International plc
ENDP
| $4K | ﹤0.01% |
15,000
-5,000
| -25% | -$99.4K |
|
|
RAX
334
CALL
DELISTED
Rackspace Hosting Inc
RAX
| $4K | ﹤0.01% |
+36,500
| New | +$1.01M |
|
335
CALL
Arcturus Therapeutics
ARCT
$172M
| $3K | ﹤0.01% |
+2,857
| New | +$92.3K |
|
336
CALL
Campbell Soup
CPB
$6.58B
| $3K | ﹤0.01% |
28,400
-25,500
| -47% | -$1.54M |
|
337
CALL
Harley-Davidson
HOG
$2.8B
| $3K | ﹤0.01% |
+800
| New | +$41.4K |
|
338
CALL
Jazz Pharmaceuticals
JAZZ
$15.5B
| $3K | ﹤0.01% |
25,100
+1,000
| +4% | +$135K |
|
339
PUT
Kohl's
KSS
$1.96B
| $3K | ﹤0.01% |
5,000
-15,000
| -75% | -$628K |
|
340
CALL
Larimar Therapeutics
LRMR
$384M
| $3K | ﹤0.01% |
3,542
-291
| -8% | -$13.2K |
|
341
PUT
Verizon
VZ
$182B
| $3K | ﹤0.01% |
15,000
| – | – |
|
342
PUT
Western Digital
WDC
$164B
| $3K | ﹤0.01% |
10,494
-5,051
| -32% | -$190K |
|
343
CALL
American International
AIG
$42.7B
| $2K | ﹤0.01% |
+25,000
| New | +$1.43M |
|
344
CALL
Designer Brands
DBI
$290M
| $2K | ﹤0.01% |
25,000
+10,000
| +67% | +$235K |
|
|
345
PUT
Designer Brands
DBI
$290M
| $2K | ﹤0.01% |
+5,000
| New | +$117K |
|
346
CALL
KLA
KLAC
$278B
| $2K | ﹤0.01% |
7,000
-42,000
| -86% | -$302K |
|
347
CALL
Kinder Morgan
KMI
$71.9B
| $2K | ﹤0.01% |
15,600
| – | – |
|
348
CALL
Terex
TEX
$7.47B
| $2K | ﹤0.01% |
14,000
-2,200
| -14% | -$51.3K |
|
|
XLNX
349
PUT
DELISTED
Xilinx Inc
XLNX
| $2K | ﹤0.01% |
+1,200
| New | +$61.7K |
|
|
AET
350
CALL
DELISTED
Aetna Inc
AET
| $2K | ﹤0.01% |
14,600
+2,100
| +17% | +$246K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q3 2016 Portfolio in Review
As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.
- FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
- FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
- FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
- FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
- FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
- FT Options opened 153 new positions and closed 127 in Q3 2016.
- FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.
Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.